{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:48:10Z","timestamp":1778806090354,"version":"3.51.4"},"reference-count":47,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Tiantan Hospital of Capital Medical University","award":["KYSQ 2020-092-01"],"award-info":[{"award-number":["KYSQ 2020-092-01"]}]},{"name":"Beijing Tiantan Hospital of Capital Medical University","award":["ZYLX202108"],"award-info":[{"award-number":["ZYLX202108"]}]},{"name":"Beijing Hospital Authority Clinical Medicine Development of Special Funding","award":["KYSQ 2020-092-01"],"award-info":[{"award-number":["KYSQ 2020-092-01"]}]},{"name":"Beijing Hospital Authority Clinical Medicine Development of Special Funding","award":["ZYLX202108"],"award-info":[{"award-number":["ZYLX202108"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Currently, no tests can definitively diagnose and distinguish neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS). Methods: Initially, cerebrospinal fluid (CSF) proteomics were employed to uncover the novel biomarkers that differentiate NMOSD from MS into cohorts of 10 MS and 10 NMOSD patients. Subsequently, screening biomarkers were validated using an enzyme-linked immunosorbent assay method and CSF and serum samples from 20 MS patients, 20 NMOSD patients, 20 non-inflammatory neurological controls, and 20 healthy controls. Results: In study cohort, insulin-like growth factor-binding protein 7 (IGFBP7) and lysosome-associated membrane glycoprotein 2 (LAMP2) were screened. In validation cohort, serum and CSF IGFBP7 not only exhibited higher levels in MS and NMOSD patients than controls, but also had greatest area under the curve (AUC, above or equal to 0.8) in MS and NMOSD diagnoses. Serum IGFBP7 (0.945) and CSF IGFBP7 (0.890) also had the greatest AUCs for predicting MS progression, while serum LAMP2 had a moderate curve (0.720). Conclusions: IGFBP7 was superior in diagnosing MS and NMOSD, and IGFBP7 and serum LAMP2 performed exceptionally well in predicting the MS progression. These results offered reasons for further investigations into the functions of IGFBP7 and LAMP2 in MS and NMOSD.<\/jats:p>","DOI":"10.3390\/diagnostics13091572","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T01:33:40Z","timestamp":1682645620000},"page":"1572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Ting","family":"Xu","sequence":"first","affiliation":[{"name":"Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"},{"name":"NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing 100070, China"},{"name":"Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Shi","sequence":"additional","affiliation":[{"name":"Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"},{"name":"NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing 100070, China"},{"name":"Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"},{"name":"NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing 100070, China"},{"name":"Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"},{"name":"NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing 100070, China"},{"name":"Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing 100070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Monaco, S., Nicholas, R., Reynolds, R., and Magliozzi, R. (2020). Intrathecal Inflammation in Progressive Multiple Sclerosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218217"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Toczylowska, B., Zieminska, E., Podlecka-Pietowska, A., Ruszczynska, A., and Chalimoniuk, M. (2022). Serum metabolic profiles and metal levels of patients with multiple sclerosis and patients with neuromyelitis optica spectrum disorders\u2014NMR spectroscopy and ICP-MS studies. Mult. Scler. Relat. Disord., 60.","DOI":"10.1016\/j.msard.2022.103672"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/1352458512439439","article-title":"Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?","volume":"18","author":"Kim","year":"2012","journal-title":"Mult. Scler. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: State-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_7","first-page":"1","article-title":"The latest diagnostic criteria and treatment options for neuromyelitis optica","volume":"32","author":"Moore","year":"2019","journal-title":"JAAPA J. Am. Acad. Physician Assist."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1474-4422(18)30159-5","article-title":"Applying the 2017 McDonald diagnostic criteria for multiple sclerosis","volume":"17","author":"Petzold","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Maciak, K., Pietrasik, S., Dziedzic, A., Redlicka, J., Saluk-Bijak, J., Bijak, M., Wlodarczyk, T., and Miller, E. (2021). Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic\u2019s Disease) and Multiple Sclerosis\u2014A Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168946"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrneurol.2015.173","article-title":"Body fluid biomarkers for multiple sclerosis\u2014The long road to clinical application","volume":"11","author":"Teunissen","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sandi, D., Kokas, Z., Biernacki, T., Bencsik, K., Klivenyi, P., and Vecsei, L. (2022). Proteomics in Multiple Sclerosis: The Perspective of the Clinician. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095162"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Thoman, M.E., and McKarns, S.C. (2020). Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery. Metabolites, 10.","DOI":"10.3390\/metabo10090374"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kowarik, M.C., Dzieciatkowska, M., Wemlinger, S., Ritchie, A.M., Hemmer, B., Owens, G.P., and Bennett, J.L. (2015). The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations. J. Neuroinflamm., 12.","DOI":"10.1186\/s12974-015-0240-9"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23595","article-title":"Cerebrospinal fluid proteomics: A new window for understanding human demyelinating disorders?","volume":"71","author":"Bennett","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ana.22633","article-title":"Proteomic pattern analysis discriminates among multiple sclerosis-related disorders","volume":"71","author":"Komori","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/mmr.2012.1025","article-title":"Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients","volume":"6","author":"Jiang","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2016.09.001","article-title":"Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis","volume":"462","author":"Lee","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.4238\/2014.February.14.3","article-title":"Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients","volume":"13","author":"Jiang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nielsen, H.H., Beck, H.C., Kristensen, L.P., Burton, M., Csepany, T., Simo, M., Dioszeghy, P., Sejbaek, T., Grebing, M., and Heegaard, N.H. (2015). The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139659"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/acs.jproteome.8b00235","article-title":"Comparison of In-Solution, FASP, and S-Trap Based Digestion Methods for Bottom-Up Proteomic Studies","volume":"17","author":"Ludwig","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shi, Y., Ding, Y., Li, G., Wang, L., Osman, R.A., Sun, J., Qian, L., Zheng, G., and Zhang, G. (2021). Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.700031"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Stachowska, L., Koziarska, D., Karakiewicz, B., Kotwas, A., Knyszynska, A., Folwarski, M., Dec, K., Stachowska, E., Hawrylkowicz, V., and Kulaszynska, M. (2022). Hepcidin (rs10421768), Transferrin (rs3811647, rs1049296) and Transferrin Receptor 2 (rs7385804) Gene Polymorphism Might Be Associated with the Origin of Multiple Sclerosis. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19116875"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Li, X., Chu, Y., Ma, R., Dou, M., Li, S., Song, Y., Lv, Y., and Zhu, L. (2022). Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis. J. Neuroimmunol., 373.","DOI":"10.1016\/j.jneuroim.2022.577995"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1523\/JNEUROSCI.3920-13.2015","article-title":"Spiral ganglion degeneration and hearing loss as a consequence of satellite cell death in saposin B-deficient mice","volume":"35","author":"Akil","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.022","article-title":"The protective role of prosaposin and its receptors in the nervous system","volume":"1585","author":"Meyer","year":"2014","journal-title":"Brain Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bechara, R., Amatya, N., Majumder, S., Zhou, C., Li, Y., Liu, Q., McGeachy, M.J., and Gaffen, S.L. (2022). The RNA-binding protein IMP2 drives a stromal-Th17 cell circuit in autoimmune neuroinflammation. JCI Insight, 7.","DOI":"10.1172\/jci.insight.152766"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","article-title":"IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties","volume":"29","author":"Du","year":"2019","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.18632\/oncoscience.306","article-title":"Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21(st) century cancer therapeutics","volume":"3","author":"Zhou","year":"2016","journal-title":"Oncoscience"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/path.5203","article-title":"A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1","volume":"247","author":"Tasaki","year":"2019","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/pin.13199","article-title":"EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) amyloid deposits in the lower rectum from aged patient with bloody stools","volume":"72","author":"Tasaki","year":"2022","journal-title":"Pathol. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2015.03.082","article-title":"Insulin-like growth factor-binding protein 7 is up-regulated during EAE and inhibits the differentiation of oligodendrocyte precursor cells","volume":"460","author":"Tan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2004.03.011","article-title":"Multiple sclerosis as a generalized CNS disease\u2014Comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS","volume":"152","author":"Lindberg","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41582-020-0378-7","article-title":"Combining biomarkers to profile multiple sclerosis patients","volume":"16","author":"Stefano","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.25808","article-title":"Identifying Progression in Multiple Sclerosis: New Perspectives","volume":"88","author":"Filippi","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/1352458520924586","article-title":"Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina","volume":"27","author":"Rojas","year":"2021","journal-title":"Mult. Scler."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.20469","article-title":"Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination","volume":"55","author":"Zeger","year":"2007","journal-title":"Glia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1002\/jcb.26654","article-title":"IGFBP-7 inhibits the differentiation of oligodendrocyte precursor cells via regulation of Wnt\/beta-Catenin signaling","volume":"119","author":"Li","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1177\/0271678X17701460","article-title":"Response of the cerebral vasculature following traumatic brain injury","volume":"37","author":"Salehi","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2018.02.009","article-title":"CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis","volume":"117","author":"Zhou","year":"2018","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_42","unstructured":"The Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature, 447, 661\u2013678."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/ard.2010.140111","article-title":"Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population","volume":"70","author":"Zhou","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1096\/fj.09-137323","article-title":"Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells","volume":"24","author":"Xu","year":"2010","journal-title":"FASEB J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/15548627.2019.1628538","article-title":"PLA2G4A\/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma","volume":"16","author":"Sarkar","year":"2020","journal-title":"Autophagy"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Januzzi, J.L., Packer, M., Claggett, B., Liu, J., Shah, A.M., Zile, M.R., Pieske, B., Voors, A., Gandhi, P.U., and Prescott, M.F. (2018). IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients with Heart Failure. Circ. Heart Fail., 11.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005133"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jin, L., Shen, F., Weinfeld, M., and Sergi, C. (2020). Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00727"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/9\/1572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:24:32Z","timestamp":1760124272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/9\/1572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["diagnostics13091572"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13091572","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]}}}